Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.
about
Metabolomics in plants and humans: applications in the prevention and diagnosis of diseasesLimited brain metabolism changes differentiate between the progression and clearance of rabies virusSources of variability in metabolite measurements from urinary samples.Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study.Serum Metabolic Profiling Reveals Altered Metabolic Pathways in Patients with Post-traumatic Cognitive Impairments.Blood metabolite markers of cognitive performance and brain function in aging.Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer's Disease Pathogenesis.Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.FTIR and Raman Spectroscopy Applied to Dementia Diagnosis Through Analysis of Biological Fluids.Grey-matter volume as a potential feature for the classification of Alzheimer's disease and mild cognitive impairment: an exploratory study.Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.Serum profile changes in postpartum women with a history of childhood maltreatment: a combined metabolite and lipid fingerprinting study.Capillary Electrophoresis in Metabolomics.Anti-Oxidant and Anti-Inflammatory Activity of Ketogenic Diet: New Perspectives for Neuroprotection in Alzheimer's Disease.NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations
P2860
Q27016117-3D451A3D-F435-43D6-8C33-946A1DD59C2FQ27325456-54BC8653-630A-41F1-8749-A107946E99BEQ33553282-4BE68F04-602A-4091-9435-D248865EF5B6Q34994418-25057684-D94B-444B-8678-D140FCA3A35DQ36587769-39C2CBD1-5D99-4A5B-ABC0-566AECD2AD28Q37057711-5CCEECF3-42FA-4644-B3E0-0990975ED327Q38222874-F29185F1-E9C1-433D-AE5E-36BF17A9A816Q38401864-8FE073AB-D443-43AA-8D80-7E44A84B1588Q38612032-7E988205-F31C-4B1C-A48D-AB8EDB3D5EBCQ38808541-52280695-9A5B-467F-9F9A-4F7C1C96E1F8Q41458145-C9854646-E92A-46B7-8815-93736AAE873EQ47407570-D4F83E72-BE74-4D2B-80D3-A243871E9BEBQ50348510-4CF51D9D-C31A-4C3B-8360-0F973BF1614BQ52917635-919628B5-C6B0-4389-A467-86C69143079DQ53513676-4CB333B1-7A1C-4D58-B021-CD8248B94D69Q57016043-138BB622-ED07-48F9-A4CE-1629963FB85B
P2860
Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Metabolomics: a novel approach ...... enesis in Alzheimer's disease.
@en
type
label
Metabolomics: a novel approach ...... enesis in Alzheimer's disease.
@en
prefLabel
Metabolomics: a novel approach ...... enesis in Alzheimer's disease.
@en
P2860
P921
P1476
Metabolomics: a novel approach ...... enesis in Alzheimer's disease.
@en
P2093
P2860
P2888
P304
P356
10.1007/S12264-012-1272-0
P577
2012-10-03T00:00:00Z